Losing weight is the best way to tackle these issues
Wegovy, with its higher dosing compared to Ozempic, is specifically approved for chronic weight management in adult patients facing obesity challenges
It helps maintain healthy cholesterol and blood sugar levels, as well as GI microbial balance
With 97% frailty prevalence and a mean 5 comorbidities (diabetes, obesity, hypertension, pulmonary, renal disease), this cohort mirrors CKM stage 4 phenotypes, supporting feasibility in this population (37)
Particularly prevalent in those over 70, where it reaches up to 10%, HF has long been recognized as a potential cause of cognitive dysfunction, sometimes referred to as cardiogenic dementia (Liu et al., 2024)
However, its effects may vary among individuals, and more research is needed to establish its long-term safety and efficacy fully